99 related articles for article (PubMed ID: 14664733)
21. IV. Current Status and Future Perspectives in Low-Grade Serous Cancer of the Ovary.
Siemon J; Gershenson D; Slomovitz B; Schlumbrecht M
Gan To Kagaku Ryoho; 2018 Feb; 45(2):247-255. PubMed ID: 29483415
[No Abstract] [Full Text] [Related]
22. Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
Hasenburg A; Tong XW; Rojas-Martinez A; Nyberg-Hoffman C; Kieback CC; Kaplan A; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
Cancer Gene Ther; 2000 Jun; 7(6):839-44. PubMed ID: 10880013
[TBL] [Abstract][Full Text] [Related]
23. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
24. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
[TBL] [Abstract][Full Text] [Related]
25. [Metastasis of a papillary cystadenocarcinoma of the ovary in an axillary lymph node].
Treumann T; Hof N; Höss C; Kolben M; Nathrath W
Rofo; 1998 Mar; 168(3):302-4. PubMed ID: 9551122
[No Abstract] [Full Text] [Related]
26. Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma.
Silva EG; Tornos CS; Malpica A; Gershenson DM
Mod Pathol; 1997 Jul; 10(7):663-7. PubMed ID: 9237175
[TBL] [Abstract][Full Text] [Related]
27. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
28. [A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis].
Mizutani H; Katabuchi H; Nakamura M; Matsuura K; Ito M; Okamura H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1139-42. PubMed ID: 8245594
[No Abstract] [Full Text] [Related]
29. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
Hinson SA; Silva EG; Pinto K
Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
[TBL] [Abstract][Full Text] [Related]
30. [Recurrence of malignant cilioepithelial ovarian cysts and their treatment].
Vinokurov VL
Vopr Onkol; 1972; 18(4):50-3. PubMed ID: 5028430
[No Abstract] [Full Text] [Related]
31. Treatment of inoperable ovarian cancer with interleukin-2 and carboplatinum.
Malaguarnera M; Scollo P; Ruggeri R; Caudullo S; Pistone G
Lancet; 1995 Dec; 346(8990):1627. PubMed ID: 7500766
[No Abstract] [Full Text] [Related]
32. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
[TBL] [Abstract][Full Text] [Related]
33. Serous papillary cystadenocarcinoma in supernumerary ovary.
Nomelini RS; Oliveira LJ; Jammal MP; Adad SJ; Murta EF
J Obstet Gynaecol; 2013 Apr; 33(3):324. PubMed ID: 23550880
[No Abstract] [Full Text] [Related]
34. Serous papillary cystadenocarcinoma arising from autografted ovary of the abdominal wall.
Gong W; Cheng H; Yan Q; Huang G; Luo P; Wang Z
Int J Surg Pathol; 2010 Oct; 18(5):398-400. PubMed ID: 19147508
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.
Baiocchi G; Ferreira FO; Mantoan H; da Costa AA; Faloppa CC; Kumagai LY; de Mello CA; Takahashi RM; Nakagawa WT; Aguiar S; Lopes A
Ann Surg Oncol; 2016 Apr; 23(4):1294-301. PubMed ID: 26628430
[TBL] [Abstract][Full Text] [Related]
36. Prolonged relapse-free survival in two patients with an isolated brain metastasis from epithelial ovarian carcinoma.
Choo BA; Walji N; Spooner D; Barber P; Fernando IN
J Clin Oncol; 2010 Jun; 28(17):e271-2. PubMed ID: 20385985
[No Abstract] [Full Text] [Related]
37. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma.
Killackey MA; Davis AR
Gynecol Oncol; 1993 Nov; 51(2):171-4. PubMed ID: 8276289
[TBL] [Abstract][Full Text] [Related]
38. [Treatment results in endometrial cancer in patients of reproductive age].
Vishnevskaia EE
Vopr Onkol; 2006; 52(4):451-4. PubMed ID: 17024821
[TBL] [Abstract][Full Text] [Related]
39. Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy.
Petrillo M; Ferrandina G; Fagotti A; Vizzielli G; Margariti PA; Pedone AL; Nero C; Fanfani F; Scambia G
Ann Surg Oncol; 2013 Nov; 20(12):3955-60. PubMed ID: 23838915
[TBL] [Abstract][Full Text] [Related]
40. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
